Rocket Lab Corporation $RKLB Holdings Lessened by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. reduced its holdings in shares of Rocket Lab Corporation (NASDAQ:RKLB) by 20.6% in the third quarter, Holdings Channel reports. The institutional investor owned 42,790 shares of the rocket manufacturer’s stock after selling 11,104 shares during the period. Oppenheimer & Co. Inc.’s holdings in Rocket Lab were worth $2,982,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in RKLB. Highland Investment Advisors LLC acquired a new stake in shares of Rocket Lab in the 2nd quarter worth about $30,000. Meeder Asset Management Inc. bought a new position in Rocket Lab in the 2nd quarter valued at about $30,000. NBH Bank acquired a new position in Rocket Lab during the 2nd quarter valued at about $30,000. Cherry Tree Wealth Management LLC acquired a new position in Rocket Lab during the 2nd quarter valued at about $32,000. Finally, Hilton Head Capital Partners LLC increased its holdings in Rocket Lab by 3,590.0% during the 3rd quarter. Hilton Head Capital Partners LLC now owns 369 shares of the rocket manufacturer’s stock worth $26,000 after purchasing an additional 359 shares in the last quarter. 71.78% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several analysts have recently commented on RKLB shares. Bank of America lowered their price objective on Rocket Lab from $115.00 to $110.00 and set a “buy” rating for the company in a research note on Monday, August 31st. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Rocket Lab in a research report on Thursday, October 15th. Raymond James Financial started coverage on Rocket Lab in a research report on Friday, September 11th. They set an “outperform” rating and a $80.00 target price on the stock. Cantor Fitzgerald reiterated a “mixed” rating and set a $122.00 price target on shares of Rocket Lab in a report on Thursday, October 15th. Finally, Berenberg Bank assumed coverage on Rocket Lab in a research report on Wednesday, September 2nd. They issued a “buy” rating and a $83.00 price target for the company. Three research analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $102.05.

Key Headlines Impacting Rocket Lab

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Rocket Lab continues to make operational progress: Neutron’s second stage and thrust module have reached Wallops Island, Virginia, for ground testing, while the company is preparing to ship its 100th Electron rocket. These milestones suggest development is advancing despite the launch delay. RKLB Stock Tests Bulls’ Patience
• Positive Sentiment: Analysts and bullish investors continue to point to Rocket Lab’s expanding business, including strong revenue growth, a reported $2.36 billion backlog, NASA-related opportunities, Iridium work and Mynaric exposure. Some forecasts argue that a successful Neutron milestone could eventually prompt a significant re-rating toward $100. Price Prediction: Rocket Lab Stock Will Hit $100
• Neutral Sentiment: The bullish investment thesis remains intact for some investors, but the Neutron delay changes the expected timing of revenue, launches and potential profitability. Rocket Lab’s substantial cash position and low leverage provide flexibility, though its high-growth valuation leaves the stock sensitive to schedule changes. The Neutron Delay Changes the Timeline, Not the Thesis
• Negative Sentiment: Investors are concerned that manufacturing defects in Neutron’s carbon-fiber structures—likened to trapped bubbles in a layered cake—contributed to the schedule slip. The delay increases execution risk and could lead to additional spending or dilution if development takes longer than expected. Rocket Lab Stock Lost Its Launch Date
• Negative Sentiment: An analyst fair-value estimate was trimmed from approximately $105.05 to $102.15, reflecting lower near-term expectations and greater execution risk following the Neutron delay. With Rocket Lab still unprofitable, investors are placing greater emphasis on delivery milestones rather than current earnings. Rocket Lab Fair Value Trim After Neutron Delay

Insider Transactions at Rocket Lab

In related news, CAO Agostino Ricupati sold 669 shares of the firm’s stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $69.63, for a total value of $46,582.47. Following the completion of the transaction, the chief accounting officer directly owned 26,863 shares of the company’s stock, valued at approximately $1,870,470.69. This trade represents a 2.43% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, SVP Arjun Kampani sold 7,754 shares of the firm’s stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $69.63, for a total transaction of $539,911.02. Following the completion of the transaction, the senior vice president directly owned 256,951 shares of the company’s stock, valued at approximately $17,891,498.13. This trade represents a 2.93% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders have sold 400,749 shares of company stock valued at $26,964,474. 8.40% of the stock is currently owned by insiders.

Rocket Lab Price Performance

Shares of NASDAQ:RKLB opened at $54.73 on Friday. The company has a market capitalization of $32.75 billion, a P/E ratio of -202.70 and a beta of 2.93. The company’s 50-day moving average is $64.23 and its 200 day moving average is $79.93. The company has a debt-to-equity ratio of 0.01, a quick ratio of 4.98 and a current ratio of 5.48. Rocket Lab Corporation has a fifty-two week low of $37.57 and a fifty-two week high of $151.00.

Rocket Lab (NASDAQ:RKLB) last posted its quarterly earnings data on Monday, August 10th. The rocket manufacturer reported ($0.08) EPS for the quarter, missing the consensus estimate of ($0.06) by ($0.02). Rocket Lab had a negative net margin of 21.51% and a negative return on equity of 6.48%. The firm had revenue of $234.07 million during the quarter, compared to analysts’ expectations of $231.62 million. On average, equities research analysts forecast that Rocket Lab Corporation will post -0.20 earnings per share for the current year.

About Rocket Lab

Rocket Lab USA, Inc is a space and defense company that develops and operates launch vehicles, spacecraft, satellite components and related space systems. The company serves government, commercial and scientific customers seeking access to orbit and other space-based capabilities.

Rocket Lab’s launch business is centered on Electron, a small orbital launch vehicle designed to carry satellites and other payloads into low Earth orbit. The company also develops specialized launch and hypersonic test services through programs such as HASTE, while its Neutron vehicle is intended to provide larger payload capacity and support future commercial and government missions.

Through its space systems business, Rocket Lab produces satellite platforms, flight computers, power systems, solar cells, reaction wheels, separation systems, radios and other components used in spacecraft.